Summit Therapeutics
SMMT
#2005
Rank
HK$83.57 B
Marketcap
HK$104.76
Share price
-4.64%
Change (1 day)
-49.85%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: HK$83.57 Billion

As of August 2026 Summit Therapeutics has a market cap of HK$83.57 Billion. This makes Summit Therapeutics the world's 2005th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$83.57 B-20.46%
2025HK$105.07 B0.78%
2024HK$104.25 B629.77%
2023HK$14.28 B113.7%
2022HK$6.68 B226.17%
2021HK$2.04 B-31.62%
2020HK$2.99 B258.04%
2019HK$0.83 B464.97%
2018HK$0.14 B-88.53%
2017HK$1.29 B58.3%
2016HK$0.81 B-25.29%
2015HK$1.09 B

End of Day market cap according to different sources

On Aug 15th, 2026 the market cap of Summit Therapeutics was reported to be:

HK$83.57 Billion
by Nasdaq info icon info icon
HK$83.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
HK$15.00 B-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.75 B-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
HK$1.45 B-98.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.37 B-42.11%๐Ÿ‡บ๐Ÿ‡ธ USA